NOVEL FUNCTIONALLY ENHANCED MESENCHYMAL PROGENITOR CELL CELL THERAPEUTIC COMPOSITION FOR ANTI-INFLAMMATORY INCLUDING THE SAME AND METHOD FOR PREPARING MESENCHYMAL PROGENITOR CELL

摘要

An embodiment of the present invention provides a novel functionally enhanced mesenchymal progenitor cell which performs overexpression on epidermal growth factor receptors (EGF-R) compared to mesenchymal stem cells (MSC), and performs hypoexpression on cluster differentiation 95 (CD95) compared to the mesenchymal stem cells (MSC). The novel functionally enhanced mesenchymal progenitor cell is derived from embryonic stem cells (ESC), induced pluripotent stem cells (iPSC), or somatic cell nuclear transfer cells (SCNT).